Matthew Brendon Might, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 9 | 2021 | 26 | 1.990 |
Why?
|
Rare Diseases | 5 | 2023 | 619 | 1.410 |
Why?
|
General Practice | 1 | 2023 | 98 | 0.790 |
Why?
|
Nephrology | 1 | 2023 | 263 | 0.660 |
Why?
|
Congenital Disorders of Glycosylation | 4 | 2021 | 48 | 0.550 |
Why?
|
Genetic Diseases, Inborn | 2 | 2017 | 601 | 0.500 |
Why?
|
Computational Biology | 3 | 2020 | 3505 | 0.450 |
Why?
|
Induced Pluripotent Stem Cells | 5 | 2021 | 1846 | 0.380 |
Why?
|
Prenatal Diagnosis | 1 | 2016 | 1264 | 0.330 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4107 | 0.310 |
Why?
|
Abnormalities, Multiple | 1 | 2014 | 1415 | 0.270 |
Why?
|
High-Throughput Screening Assays | 2 | 2021 | 944 | 0.220 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2024 | 376 | 0.190 |
Why?
|
Receptor, trkB | 1 | 2021 | 125 | 0.190 |
Why?
|
Physical Conditioning, Animal | 1 | 2024 | 366 | 0.180 |
Why?
|
Knowledge | 1 | 2022 | 176 | 0.180 |
Why?
|
RNA Helicases | 1 | 2021 | 146 | 0.180 |
Why?
|
Genomics | 3 | 2023 | 5794 | 0.170 |
Why?
|
Metagenomics | 1 | 2023 | 457 | 0.170 |
Why?
|
Knowledge Bases | 1 | 2020 | 98 | 0.170 |
Why?
|
Respiratory Function Tests | 1 | 2024 | 1683 | 0.160 |
Why?
|
Algorithms | 1 | 2020 | 13981 | 0.160 |
Why?
|
Megakaryocytes | 1 | 2023 | 565 | 0.160 |
Why?
|
Community-Acquired Infections | 1 | 2023 | 461 | 0.160 |
Why?
|
Mutation | 7 | 2021 | 29932 | 0.150 |
Why?
|
Proton Pumps | 1 | 2017 | 29 | 0.150 |
Why?
|
Vocabulary | 1 | 2018 | 165 | 0.150 |
Why?
|
Ventricular Remodeling | 1 | 2024 | 1261 | 0.140 |
Why?
|
Bacteremia | 1 | 2023 | 980 | 0.130 |
Why?
|
Drug Repositioning | 1 | 2018 | 232 | 0.130 |
Why?
|
Myocytes, Cardiac | 1 | 2024 | 1657 | 0.130 |
Why?
|
Lung | 2 | 2024 | 9994 | 0.120 |
Why?
|
Drosophila Proteins | 2 | 2022 | 1699 | 0.120 |
Why?
|
NF-kappa B | 1 | 2023 | 2488 | 0.120 |
Why?
|
Tandem Mass Spectrometry | 1 | 2021 | 1189 | 0.120 |
Why?
|
Biomedical Research | 2 | 2020 | 3426 | 0.110 |
Why?
|
Sequence Analysis, RNA | 2 | 2018 | 2005 | 0.110 |
Why?
|
Metformin | 1 | 2021 | 912 | 0.110 |
Why?
|
Databases, Genetic | 1 | 2020 | 1738 | 0.110 |
Why?
|
Brain Diseases | 1 | 2021 | 1540 | 0.100 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2016 | 497 | 0.100 |
Why?
|
Proton Pump Inhibitors | 1 | 2017 | 551 | 0.100 |
Why?
|
Internet | 2 | 2021 | 3078 | 0.100 |
Why?
|
Humans | 30 | 2024 | 760621 | 0.100 |
Why?
|
Genetic Association Studies | 1 | 2021 | 2717 | 0.100 |
Why?
|
Small Molecule Libraries | 1 | 2017 | 734 | 0.100 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 1664 | 0.090 |
Why?
|
Drug Discovery | 1 | 2019 | 1057 | 0.090 |
Why?
|
Signal Transduction | 1 | 2014 | 23376 | 0.090 |
Why?
|
Hospital Mortality | 2 | 2023 | 5425 | 0.090 |
Why?
|
Phenotype | 4 | 2021 | 16546 | 0.090 |
Why?
|
Patient Participation | 2 | 2018 | 1439 | 0.090 |
Why?
|
Cardiology | 1 | 2020 | 1723 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2020 | 5201 | 0.080 |
Why?
|
Language | 1 | 2018 | 1533 | 0.080 |
Why?
|
Nervous System Diseases | 1 | 2019 | 1647 | 0.080 |
Why?
|
Anticonvulsants | 1 | 2018 | 1879 | 0.080 |
Why?
|
Palliative Care | 1 | 2023 | 3607 | 0.070 |
Why?
|
Kidney | 1 | 2023 | 7064 | 0.070 |
Why?
|
Veterans | 1 | 2021 | 2642 | 0.070 |
Why?
|
Software | 2 | 2018 | 4419 | 0.070 |
Why?
|
HEK293 Cells | 3 | 2021 | 4264 | 0.070 |
Why?
|
Enzyme Inhibitors | 1 | 2017 | 3726 | 0.070 |
Why?
|
Homozygote | 2 | 2021 | 1788 | 0.060 |
Why?
|
Endoplasmic Reticulum | 2 | 2024 | 1132 | 0.060 |
Why?
|
Databases, Factual | 1 | 2020 | 8035 | 0.060 |
Why?
|
Hospitalization | 2 | 2021 | 10790 | 0.060 |
Why?
|
Heterozygote | 2 | 2021 | 2798 | 0.050 |
Why?
|
Epilepsy | 1 | 2018 | 3267 | 0.050 |
Why?
|
Interferon Regulatory Factor-2 | 1 | 2022 | 22 | 0.050 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9411 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5889 | 0.050 |
Why?
|
Wnt1 Protein | 1 | 2022 | 120 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 17790 | 0.050 |
Why?
|
Alabama | 1 | 2020 | 104 | 0.050 |
Why?
|
Cough | 1 | 2024 | 595 | 0.040 |
Why?
|
Zebrafish | 2 | 2022 | 2997 | 0.040 |
Why?
|
Male | 9 | 2024 | 359744 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2021 | 629 | 0.040 |
Why?
|
Child, Preschool | 2 | 2021 | 42063 | 0.040 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2021 | 599 | 0.040 |
Why?
|
Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 2017 | 20 | 0.040 |
Why?
|
Karyotyping | 1 | 2019 | 1171 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2019 | 786 | 0.030 |
Why?
|
Acetylglucosamine | 1 | 2018 | 189 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2021 | 1617 | 0.030 |
Why?
|
Diagnostic Self Evaluation | 1 | 2018 | 225 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 1722 | 0.030 |
Why?
|
Dyspnea | 1 | 2024 | 1352 | 0.030 |
Why?
|
Cell Line | 2 | 2021 | 15620 | 0.030 |
Why?
|
Oligopeptides | 1 | 2021 | 1187 | 0.030 |
Why?
|
Glycosaminoglycans | 1 | 2018 | 605 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10827 | 0.030 |
Why?
|
Glycosylation | 1 | 2018 | 1096 | 0.030 |
Why?
|
Data Mining | 1 | 2020 | 553 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15757 | 0.030 |
Why?
|
Infant | 1 | 2016 | 36060 | 0.030 |
Why?
|
Drosophila | 1 | 2022 | 1492 | 0.030 |
Why?
|
Female | 6 | 2024 | 391270 | 0.030 |
Why?
|
Glycoproteins | 1 | 2021 | 2208 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2024 | 3106 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2021 | 1841 | 0.030 |
Why?
|
Molecular Structure | 1 | 2017 | 1895 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2021 | 2058 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2020 | 4625 | 0.030 |
Why?
|
Animals | 5 | 2024 | 167963 | 0.030 |
Why?
|
Bacteria | 1 | 2023 | 2199 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2024 | 9530 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2023 | 2622 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2018 | 1313 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2017 | 3084 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2021 | 3707 | 0.020 |
Why?
|
Genetic Testing | 1 | 2023 | 3531 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2024 | 80372 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2022 | 4490 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2023 | 3736 | 0.020 |
Why?
|
Developmental Disabilities | 1 | 2018 | 1504 | 0.020 |
Why?
|
Cohort Studies | 2 | 2023 | 41335 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2018 | 1710 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2019 | 5870 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2022 | 4938 | 0.020 |
Why?
|
Gene Expression | 1 | 2021 | 7588 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2021 | 3150 | 0.020 |
Why?
|
Child | 3 | 2022 | 79806 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2021 | 11071 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2557 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2022 | 5791 | 0.020 |
Why?
|
Information Dissemination | 1 | 2015 | 1131 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12808 | 0.020 |
Why?
|
Seizures | 1 | 2018 | 2917 | 0.020 |
Why?
|
Risk Factors | 2 | 2023 | 74359 | 0.010 |
Why?
|
Aged | 3 | 2024 | 169152 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10344 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2019 | 18957 | 0.010 |
Why?
|
United States | 2 | 2021 | 72461 | 0.010 |
Why?
|
Middle Aged | 3 | 2024 | 220352 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8624 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2024 | 20509 | 0.010 |
Why?
|
Genetic Variation | 1 | 2015 | 6551 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 29658 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39261 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18137 | 0.010 |
Why?
|
Adult | 2 | 2023 | 219994 | 0.010 |
Why?
|
Mice | 1 | 2024 | 81208 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 65017 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 58995 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 87810 | 0.010 |
Why?
|